The myeloprotective effect of high dose medroxyprogesterone acetate (HD-MPA) in patients with carcinoma of the uterine cervix (stage II & III) treated by radiation
Journal of the Medical Association of Thailand. Vol.79, No.9 (1996)
Suggested Citation
Supatra Sangruchi The myeloprotective effect of high dose medroxyprogesterone acetate (HD-MPA) in patients with carcinoma of the uterine cervix (stage II & III) treated by radiation. Journal of the Medical Association of Thailand. Vol.79, No.9 (1996). Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/17661
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The myeloprotective effect of high dose medroxyprogesterone acetate (HD-MPA) in patients with carcinoma of the uterine cervix (stage II & III) treated by radiation